MT5111
12 Apr 2022
MT-5111
NCT04029922
Study of MT-5111 in HER2-positive Solid Tumors (MT-5111)
Molecular Templates, Inc.
Cancer Type | All cancers |
---|---|
Trial Type | Treatment |
Phase | Phase I |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | Locally Recurrent or Locally Advanced; Metastatic or Widespread |
Anticipated Start Date | 2019-11-12 |
Anticipated End Date | 2025-05-01 |
Hospital | Cancer Research SA |
---|---|
Clinical Trial Coordinator | Kelly Mead |
admin@cancerresearchsa.com.au | |
Phone | 08 8359 2565 |
Principal Investigator | Dr Meena Okera |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs